Achillion Pharmaceuticals, Inc. announced the addition of two members to the senior management team. Martha Manning, Esq., joins Achillion as executive vice president, general counsel and secretary effective February 1, 2016. In addition, Amy Jennings, Ph.D., recently joined the company and will serve as Senior Vice President of Regulatory Affairs.

Martha E. Manning, Esq. joined Achillion in February 2016 as General Counsel. Previously, she was General Counsel of iCeutica Inc. from 2013 to 2016.

She served as Chief Legal Officer of OraPharma, Inc., a J&J spinout company, from 2011 to 2012 when the Company was acquired by Valeant. Amy Jennings joined Achillion in January 2016 and serves as Senior Vice President of Regulatory Affairs. She was previously with Sanofi where she was the head of US regulatory for diabetes.

Prior to Sanofi, Amy assumed roles of increasing responsibility at Bristol-Myers Squibb within Regulatory over more than 12 years, culminating in her leading U.S. regulatory for CV/Metabolics.